Study of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's Lymphoma
Status:
Recruiting
Trial end date:
2025-05-25
Target enrollment:
Participant gender:
Summary
This is a Phase I/II, Single-Arm, Open-Label, Multicentre Study to Evaluate the Safety and
Efficacy of IMM0306 in Patients with Relapsed or Refractory B-Cell Non- Hodgkin's Lymphoma
(R/R B-NHL).